✦ LIBER ✦

Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker

✍ Scribed by Masashi Takawa; Ken Masuda; Masaki Kunizaki; Yataro Daigo; Katsunori Takagi; Yukiko Iwai; Hyun-Soo Cho; Gouji Toyokawa; Yuka Yamane; Kazuhiro Maejima; Helen I. Field; Takaaki Kobayashi; Takayuki Akasu; Masanori Sugiyama; Eijyu Tsuchiya; Yutaka Atomi; Bruce A. J. Ponder; Yusuke Nakamura; Ryuji Hamamoto

Book ID: 108587093
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 563 KB
Volume: 102
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2011.01958.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hedgehog signaling pathway as a therapeu

Hedgehog signaling pathway as a therapeutic target in various types of cancer

✍ Hideya Onishi; Mitsuo Katano 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB

The Potential of Osteopontin as a Therap

The Potential of Osteopontin as a Therapeutic Target for Human Colorectal Cancer

✍ Wang Likui; Wang Hong; Zhang Shuwen; You Yuangang; Wen Yan 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 568 KB

Serum glycoproteins and HLA types as a p

Serum glycoproteins and HLA types as a prognostic marker and individualization of treatment for gastric cancer

✍ K. Ogoshi; T. Mitomi; Y. Kondoh; K. Iwata 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 74 KB

P53 immunoexpression as a prognostic mar

P53 immunoexpression as a prognostic marker for human astrocytomas: a meta-analysis and review of the literature

✍ Georgia Levidou; Elias El-Habr; Angelica A. Saetta; Christine Bamias; Klea Katso 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 253 KB

Erratum to: P53 immunoexpression as a pr

Erratum to: P53 immunoexpression as a prognostic marker for human astrocytomas: a meta-analysis and review of the literature

✍ Georgia Levidou; Elias El-Habr; Angelica A. Saetta; Christine Bamias; Klea Katso 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 86 KB

ErbB4 increases the proliferation potent

ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy

✍ Alex Starr; Joel Greif; Akiva Vexler; Maia Ashkenazy-Voghera; Valery Gladesh; Ch 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 218 KB 👁 1 views

## Abstract Clinical and experimental data suggest that ErbB‐4, a member of the epidermal growth factor receptor family, may have a role in cancer progression and response to treatment. We found recently, using a retrospective clinical analysis, that expression of ErbB‐4 receptor is correlated with